ATE9906T1 - Verfahren zum herstellen und erhalten von anaphylatoxin und cocytotaxin enthaltenden leukotaxin-praeparaten und von anaphylatoxinund cocytotaxin-proteinen in einer molekular homogenen und biologisch aktiven form. - Google Patents

Verfahren zum herstellen und erhalten von anaphylatoxin und cocytotaxin enthaltenden leukotaxin-praeparaten und von anaphylatoxinund cocytotaxin-proteinen in einer molekular homogenen und biologisch aktiven form.

Info

Publication number
ATE9906T1
ATE9906T1 AT81104558T AT81104558T ATE9906T1 AT E9906 T1 ATE9906 T1 AT E9906T1 AT 81104558 T AT81104558 T AT 81104558T AT 81104558 T AT81104558 T AT 81104558T AT E9906 T1 ATE9906 T1 AT E9906T1
Authority
AT
Austria
Prior art keywords
cocytotaxin
anaphylatoxin
proteins
preparations
obtaining
Prior art date
Application number
AT81104558T
Other languages
English (en)
Inventor
Josef Dr. Dipl.-Chem. Wissler
Original Assignee
Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V. filed Critical Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V.
Application granted granted Critical
Publication of ATE9906T1 publication Critical patent/ATE9906T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT81104558T 1980-06-19 1981-06-12 Verfahren zum herstellen und erhalten von anaphylatoxin und cocytotaxin enthaltenden leukotaxin-praeparaten und von anaphylatoxinund cocytotaxin-proteinen in einer molekular homogenen und biologisch aktiven form. ATE9906T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19803022914 DE3022914A1 (de) 1980-06-19 1980-06-19 Verfahren zurgewinnung eines anaphylatoxin und cocytotaxin enthaltenden leukotaxinpraeparates sowie von anaphylatoxin und cocytotaxin in molekular einheitlicher form
EP81104558A EP0042560B1 (de) 1980-06-19 1981-06-12 Verfahren zum Herstellen und Erhalten von Anaphylatoxin und Cocytotaxin enthaltenden Leukotaxin-Präparaten und von Anaphylatoxin- und Cocytotaxin-Proteinen in einer molekular homogenen und biologisch aktiven Form

Publications (1)

Publication Number Publication Date
ATE9906T1 true ATE9906T1 (de) 1984-11-15

Family

ID=6104950

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81104558T ATE9906T1 (de) 1980-06-19 1981-06-12 Verfahren zum herstellen und erhalten von anaphylatoxin und cocytotaxin enthaltenden leukotaxin-praeparaten und von anaphylatoxinund cocytotaxin-proteinen in einer molekular homogenen und biologisch aktiven form.

Country Status (5)

Country Link
US (2) US4495096A (de)
EP (1) EP0042560B1 (de)
JP (1) JPS5731621A (de)
AT (1) ATE9906T1 (de)
DE (2) DE3022914A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE940698L (en) * 1984-04-05 1985-10-05 Univ Missouri Vaccine and serum for endotoxin associated disease and method of preparing same as well as to methods of immunization and treatment of such disease and to a detoxified endotoxin and bacterial mutant
JPS61235752A (ja) * 1985-04-11 1986-10-21 Asahi Optical Co Ltd 細胞分離材、分離器および分離方法
JP2536749B2 (ja) * 1986-03-22 1996-09-18 旭光学工業株式会社 細胞分離剤、その製造方法及びそれを使用した細胞分離器並びにそれを使用した免疫抑制性リンパ球、及び／又は免疫抑制因子産生細胞の除去方法
US5006259A (en) * 1988-03-21 1991-04-09 E. I. Du Pont De Nemours And Company Process and means for use of anaphylatoxin adsorbents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2710293A (en) * 1953-10-30 1955-06-07 Olin Mathieson Blood fractionation

Also Published As

Publication number Publication date
JPS5731621A (en) 1982-02-20
US4495096A (en) 1985-01-22
EP0042560B1 (de) 1984-10-17
DE3166700D1 (en) 1984-11-22
EP0042560A2 (de) 1981-12-30
US4610815A (en) 1986-09-09
DE3022914A1 (de) 1981-12-24
EP0042560A3 (en) 1982-06-09

Similar Documents

Publication Publication Date Title
US4309418A (en) Anti-tumor agent from human serum and process
DE2720704C2 (de) Neues Glycoprotein, Verfahren zu seiner Herstellung und seine Verwendung
DE69727595D1 (de) Verfahren zur herstellung eines extraktes des plättchenwachstumsfaktors für zubereitungen zur wundheilung
DE3484673D1 (de) Digitalis-antikoerper, verfahren zu ihrer herstellung und ihre verwendung zur therapie von digitalis-intoxikationen.
DE3773963D1 (de) Verfahren zur herstellung von reifem, menschlichem serum-albumin.
EP0000134B1 (de) Glykoprotein, Verfahren zu seiner Herstellung, seine Verwendung zur Gewinnung von Antiserum sowie das Antiserum
US4301064A (en) Ubiquitary tissue protein PP8
DE68915226T2 (de) Thrombin bindende Substanz und Verfahren zu ihrer Herstellung.
ES534008A0 (es) Procedimiento de separacion de las principales proteinas de la sangre hemolizada
EP0139975B1 (de) Verfahren zur Pasteurisierung von Humanplasma
ATE101345T1 (de) Selektive entfernung von immunkomplexen.
ATE9906T1 (de) Verfahren zum herstellen und erhalten von anaphylatoxin und cocytotaxin enthaltenden leukotaxin-praeparaten und von anaphylatoxinund cocytotaxin-proteinen in einer molekular homogenen und biologisch aktiven form.
Sehon et al. Electrophoretic separation of skin-sensitizing antibody from the sera of ragweed-sensitive patients
KR960009052B1 (en) Simultaneous preparation process of useful proteins from human urine
EP0146107A2 (de) Verfahren zur nacheinanderfolgenden Herstellung von humanem Leukozyteninterferon und humanem Gamma-Interferon
Kudo et al. Characterization of tumour cell aggregation promoting factor from rat ascites hepatoma cells: Separation of two factors with different antigenic property
Miribel et al. The use of dye-ligand affinity chromatography for the purification of non-enzymatic human plasma proteins
AT384032B (de) Verfahren zur herstellung von polydispersen nativen pseudomonas-flagella(h)-antigenen (fag)
ATE82471T1 (de) Verfahren zur abtrennung bestimmter proteine aus molke.
US3993585A (en) Elevated human lipids control
GB1522600A (en) Proteins
ATE106893T1 (de) Verfahren zur herstellung von aktiviertem protein c.
AT391482B (de) Verfahren zur industriellen herstellung von hochreinem menschlichem leukozyteninterferon
AT369265B (de) Verfahren zur herstellung eines antiserums gegen ein leucinreiches 3,1s-alpha2-glykoprotein
RU2068693C1 (ru) Способ получения с1-инактиватора человека

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee